Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Third Edition BOGP (10)
United Kingdom (3)
Organization / System Development
Neurology/Parkinson's Disease (1)
Pharmaceutical Company (9)
Payers (usually governmental or public bodies, reimbursement)
Transparency in communication and documentation
Clinical study phase II